Download Files:
TrkA-IN-6
SKU
HY-157168-Get quote
Category Reference compound
Tags Neurological Disease, Neuronal Signaling;Protein Tyrosine Kinase/RTK, Trk Receptor
Products Details
Product Description
– TrkA-IN-6 (compound R48) is a hydrazone-like, selective inhibitor of tropomyosin kinase type A receptor kinase (TrkA). TrkA-IN-6 exhibited a higher cytotoxic effect on U87 GBM cells than Temozolomide (HY-17364), with an IC50 of 68.99 μM[1].
Web ID
– HY-157168
Shipping
– Room temperature
Molecular Formula
– C16H13N3O5
References
– [1]Murugesan A et al. Design, synthesis and anticancer evaluation of novel arylhydrazones of active methylene compounds. Int J Biol Macromol. 2023 Nov 10;254(Pt 3):127909.
Molecular Weight
– 327.29
SMILES
– CC(/C(C(C1=CC=CC=C1)=O)=NNC2=CC=C([N+]([O-])=O)C=C2O)=O
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– Trk Receptor
Pathway
– Neuronal Signaling;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.